Accelerating Typhoid Conjugate Vaccine Introduction
This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.
Author: Typhoid Vaccine Acceleration Consortium
» Download file (English)
514 KB PDF (Located at www.path.org)
» Download file (French)
693 KB PDF (Located at www.path.org)
Also known as: Accélérer l’introduction du vaccin conjugué contre la fièvre typhoïde